In this webinar, IQVIA explores the intricate landscape of medical devices and technologies, and the complex regulatory environment that governs the industry on a global scale.

In this webinar, you will learn:

• How the role of eQMS and end-to-end workflows are essential in facilitating compliance, efficiency and strategic positioning of devices and technologies
• Why understanding the regulatory landscape, classification of devices and adherence to QMS standards, is vital for regulatory approval and market access in China
• The significance of local expertise when navigating the diverse regulatory landscape in the APAC

In the fast-paced environment of drug development, pharmaceutical companies need to mine internal and external information quickly and accurately. Many organizations are looking for innovations with NLP (Natural Language Processing), such as large language models, to accelerate drug development. In this webinar, we will discuss how AI (Artificial Intelligence) and NLP are being used at AstraZeneca to facilitate clinical trial design, diversity plans, and health authority advice within regulatory affairs.

Register now to learn about:

• What is NLP
• NLP for efficacy endpoints and clinical trial design
• NLP to accelerate diversity plans preparation
• NLP implementation into digital platform to mine health authority advice

Gain first-hand knowledge and specialised perspectives on the latest trends:

• Acquire insights into the influence of AI, machine learning, and large language models (LLMs) on safety, MI, and regulatory compliance
• Hear how new technologies will be integrated into a combined safety services and technology model
• Discover the essential strategies for optimising operations and integrating pharmacovigilance with medical intelligence
• Learn the effects of AI and NLP advancements on lifecycle safety

Don’t miss these insights from Pharma Ignite, presented in partnership with IQVIA.

• Examine the growing importance of HEOR.
• Understand HEOR’s role in monitoring and improving quality of care and generating real world data.
• Learn how to overcome industry challenges using the right data assets.
• Get to know a partner experienced in supporting HEOR studies.
• Explore ways to create and communicate a compelling product narrative and value proposition

Watch now for answers to these questions and more:

• What is an external comparator and where can we see these specifications?
• What is the FDA draft guidance on real world evidence (RWE)?
• What are the indications for external comparators?
• What are the best practices for fit-for-purpose real world data (RWD) and RWE?

Watch your free, on-demand webinar from Pharma Ignite, presented in partnership with IQVIA, for insights into innovative approaches to creating RWE and using it to communicate the value of your products.

Watch now to explore:

• Trends in retrospective healthcare research innovation
• Innovative approaches and solutions to complicated health economics research questions
• Recent case studies illustrating how IQVIA helped customers generate the required RWE

Download these fresh insights now for an inside look at RWE’s current use and future potential.

• Explore RWE’s role in supplementing clinical trial evidence and reducing oncology HTA body uncertainties.
• Examine the use of RWE in HTA evaluations to inform final pricing and reimbursement decisions.
• Understand key drivers and historic barriers of RWE acceptance
• Discover European initiatives and strategies being used to standardize and optimize how RWE is evaluated

Access on-demand insights in this hour-long webinar from Pharma Ignite, presented in partnership with IQVIA.

Watch now for answers to these questions and more:

• What is an external comparator and where can we see these specifications?
• What is the FDA draft guidance on real world evidence (RWE)?
• What are the indications for external comparators?
• What are the best practices for fit-for-purpose real world data (RWD) and RWE?

View the webinar on-demand to discover:

• How to overcome common data quality challenges
• How you can apply data quality concepts in your organization
• How data quality measures can help provide transparency for better research
• IQVIA’s systematic approach to monitoring data quality
• Use cases for RWD application and utilization

Experts will discuss:

• The current pharmaceutical regulatory landscape and to what degree the latest Argus version supports it
• Whether the out-of-the-box functions of Argus 8.4 and 8.4.1 meet business’ needs or require additional configuration or customization
• What features can be expected in future releases of pharmaceutical safety systems, specifically Argus 8.4.2